Ame Company For Medical Supplies
TADAWUL:9527.SR
118 (SAR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 114.532 | 54.662 | 66.909 | 102.981 | 51.491 | 54.171 | 84.823 | 54.057 | 81.603 | 37.622 |
| Cost of Revenue
| 71.795 | 31.322 | 37.637 | 60.743 | 29.959 | 28.99 | 43.878 | 27.417 | 44.373 | 20.792 |
| Gross Profit
| 42.737 | 23.341 | 29.273 | 42.238 | 21.531 | 25.181 | 40.945 | 26.641 | 37.23 | 16.829 |
| Gross Profit Ratio
| 0.373 | 0.427 | 0.437 | 0.41 | 0.418 | 0.465 | 0.483 | 0.493 | 0.456 | 0.447 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 3.903 | 4.159 | 0 | 3.908 | 3.32 | 0 | 4.396 | 0 | 2.888 |
| Selling & Marketing Expenses
| 0 | 10.827 | 12 | 0 | 8.933 | 10.729 | 0 | 10.332 | 0 | 7.305 |
| SG&A
| 25.358 | 14.73 | 15.384 | 29.77 | 15.521 | 14.048 | 28.224 | 14.728 | 20.522 | 10.192 |
| Other Expenses
| 0 | -5.801 | -0.306 | -0 | -0.401 | 0 | 0 | 0 | -1.07 | 0 |
| Operating Expenses
| 25.358 | 8.929 | 15.078 | 29.77 | 15.12 | 15.12 | 28.224 | 16.357 | 21.592 | 14.149 |
| Operating Income
| 17.378 | 14.412 | 14.195 | 12.468 | 6.411 | 10.06 | 12.721 | 10.284 | 15.638 | 2.68 |
| Operating Income Ratio
| 0.152 | 0.264 | 0.212 | 0.121 | 0.125 | 0.186 | 0.15 | 0.19 | 0.192 | 0.071 |
| Total Other Income Expenses Net
| 3.889 | 0.335 | 0.194 | 0.76 | 0.203 | 0.066 | 0.116 | -0.029 | -0.282 | -0.048 |
| Income Before Tax
| 21.267 | 14.748 | 14.388 | 13.228 | 6.614 | 10.004 | 12.836 | 10.255 | 15.356 | 2.632 |
| Income Before Tax Ratio
| 0.186 | 0.27 | 0.215 | 0.128 | 0.128 | 0.185 | 0.151 | 0.19 | 0.188 | 0.07 |
| Income Tax Expense
| 2.459 | 1.205 | 1.092 | 1.909 | 0.955 | 0.81 | 1.529 | 0.75 | 1.632 | 0.712 |
| Net Income
| 18.808 | 13.543 | 13.296 | 11.319 | 5.659 | 9.194 | 11.307 | 9.505 | 13.725 | 1.92 |
| Net Income Ratio
| 0.164 | 0.248 | 0.199 | 0.11 | 0.11 | 0.17 | 0.133 | 0.176 | 0.168 | 0.051 |
| EPS
| 2.69 | 1.93 | 1.9 | 1.62 | 0.81 | 3.17 | 1.62 | 1.36 | 1.96 | 0.27 |
| EPS Diluted
| 2.69 | 1.93 | 1.9 | 1.62 | 0.81 | 3.17 | 1.62 | 1.36 | 1.96 | 0.27 |
| EBITDA
| 22.683 | 14.586 | 14.368 | 14.598 | 6.311 | 25.175 | 13.199 | 10.284 | 15.822 | 2.68 |
| EBITDA Ratio
| 0.198 | 0.267 | 0.215 | 0.142 | 0.123 | 0.465 | 0.156 | 0.19 | 0.194 | 0.071 |